Refractory chronic lymphocytic leukemia – new therapeutic strategies

Treatment outcome of chronic lymphocytic leukemia (CLL) has considerably improved since the introduction of fludarabine (F) as part of the standard therapy. Nevertheless, refractoriness to fludarabine occurs in a significant number of patients and is associated with an unfavorable prognosis. Importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnaiter, Andrea, Stilgenbauer, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248129/
https://www.ncbi.nlm.nih.gov/pubmed/21317446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248129/
https://www.ncbi.nlm.nih.gov/pubmed/21317446

Ejemplares similares